Histological Benefit of Retreatment by Pegylated Interferon Alfa-2b and Ribavirin in Patients with Recurrent Hepatitis C Virus Infection Posttransplantation
Open Access
- 1 February 2007
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (2) , 448-453
- https://doi.org/10.1111/j.1600-6143.2006.01619.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantationLiver Transplantation, 2005
- Hepatitis C and liver transplantationNature, 2005
- Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantationLiver Transplantation, 2004
- Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipientsHepatology, 2002
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantationHepatology, 1997
- An algorithm for the grading of activity in chronic hepatitis CHepatology, 1996
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996
- Variability of hepatitis C virusHepatology, 1995
- Variability of hepatitis C virusHepatology, 1995